Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
Jeffrey L. Saver(University of California, Los Angeles), Lee H. Schwamm(Yale University), DaiWai M. Olson(Nanotherapeutics (United States)), Mathew J. Reeves(Michigan State University), Maria V. Grau‐Sepulveda(Duke University), Eric D. Peterson(The University of Texas Southwestern Medical Center), Gregg C. Fonarow(UCLA Medical Center), Adrian F. Hernandez(Duke University), Wenqin Pan(Duke University), Eric E. Smith(University of Calgary)
Cited by 869
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k